| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/19/2006 | CA2573309A1 Transmucosal administration agent containing pth |
| 01/19/2006 | CA2570518A1 Tetracyclic compounds as estrogen ligands |
| 01/19/2006 | CA2561841A1 Methods for suppressing neovascularization using ephrinb2 |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616867A1 Hydroxycarboxylic acid derivatives |
| 01/18/2006 | EP1616866A1 M-stage kinesin inhibitor |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616859A1 Substituted cyclohexyl carboxylic acid compounds |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615885A1 B -fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615664A1 Pharmaceutical composition for treatment of immunological disorders |
| 01/18/2006 | EP1501505B1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -triazole for the treatment of autoimmune diseases |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1292590B1 Admantane derivatives |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1232183B1 Peptides having antiangiogenic activity |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1212335B1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723024A Method for the treatment of bone disorders |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1720999A Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof |
| 01/18/2006 | CN1720973A Compound drop pills of stramonium and its preparation method |
| 01/18/2006 | CN1720967A Inflammation-resisting pain-stopping preparation |
| 01/18/2006 | CN1720961A Medicinal incense for dispelling wind-dampness and method for manufacturing the same |
| 01/18/2006 | CN1720953A Method for preparing gene-caring weight-reducing medicine |
| 01/18/2006 | CN1720950A Compound drop pills of Chinese angelica and its preparation method |
| 01/18/2006 | CN1720948A Dripping pills of lllicium henryi dripping pills and method for preparing the same |
| 01/18/2006 | CN1720947A Dripping pills with mistletoe and Chinese angelica root and process for preparing the same |
| 01/18/2006 | CN1720946A Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same |
| 01/18/2006 | CN1720943A Medicinal composition for treating hyperuricemia and gouty nephropthy |
| 01/18/2006 | CN1720939A Instant pain-stopping medicament |
| 01/18/2006 | CN1720938A Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process |
| 01/18/2006 | CN1720937A Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof |
| 01/18/2006 | CN1720933A Tendon and bone strengthening capsule |
| 01/18/2006 | CN1720928A Bone-setting pain-stopping plaster |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236815C Application of integrin antagonists in preparation of medicine for treating multiple myeloma and myeloma-induced bone resorption |
| 01/18/2006 | CN1236809C Trauma treating medicament and method for making same |
| 01/18/2006 | CN1236803C Rheuamtism treating Chinese medicine |
| 01/18/2006 | CN1236798C External medicine for treating bone tuberculosis |
| 01/18/2006 | CN1236793C Medicinal formula for treating sciatic nerve disease and protrusion of lumbar intervertebral disc |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236785C Effective component extracting method from gettama leaf, bark or seed as material |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987116 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987100 Pharmaceutical compositions for treating bone lesions in multiple myeloma |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986888 Method for treating mammals with modified mammalian blood |
| 01/17/2006 | CA2346171C Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/12/2006 | WO2006004385A1 Bio-stimulating medicinal agent for locomotor apparatus |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2006003290A2 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | US20060009412 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060008574 Galactosyl isomalt, method for production and use thereof |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572321A1 Anti-synoviolin antibody |
| 01/12/2006 | CA2572126A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 01/12/2006 | CA2572125A1 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 01/12/2006 | CA2572119A1 Combination therapies utilizing benzamide inhibitors of the p2x7 receptor |
| 01/12/2006 | CA2572118A1 Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 01/12/2006 | CA2571742A1 Canine osteoarthritis diet formulation |
| 01/12/2006 | CA2571577A1 S1-5 containing protein preparation |
| 01/12/2006 | CA2571536A1 Compositions and methods for treating inflammatory disorders |
| 01/12/2006 | CA2570224A1 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 01/12/2006 | CA2570199A1 Use of highly sulfated polysaccharide derivatives of low molar mass for modulating angiogenesis |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1614697A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |